| scholarly article | Q13442814 |
| P50 | author | Giulio Superti-Furga | Q951559 |
| Timo Glatter | Q56508056 | ||
| Andreas Pichlmair | Q61305839 | ||
| Friedemann Weber | Q40182480 | ||
| Matthias Habjan | Q46151229 | ||
| P2093 | author name string | Matthias Gstaiger | |
| Richard M Elliott | |||
| Anna K Overby | |||
| Hermann Unger | |||
| P2860 | cites work | An integrated workflow for charting the human interaction proteome: insights into the PP2A system | Q24318802 |
| Antiviral actions of interferons | Q24550676 | ||
| Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response | Q24681387 | ||
| The S Segment of Punta Toro Virus (Bunyaviridae, Phlebovirus) Is a Major Determinant of Lethality in the Syrian Hamster and Codes for a Type I Interferon Antagonist | Q27478045 | ||
| Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein | Q27480330 | ||
| La Crosse Bunyavirus Nonstructural Protein NSs Serves To Suppress the Type I Interferon System of Mammalian Hosts | Q27480353 | ||
| The response of mammalian cells to double-stranded RNA | Q27481673 | ||
| Emerging viruses: the Bunyaviridae | Q27485354 | ||
| Processing of Genome 5′ Termini as a Strategy of Negative-Strand RNA Viruses to Avoid RIG-I-Dependent Interferon Induction | Q27485881 | ||
| The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection | Q27485926 | ||
| Interferon-inducible antiviral effectors | Q27486790 | ||
| RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates | Q27861007 | ||
| 5'-Triphosphate RNA is the ligand for RIG-I | Q28131726 | ||
| The dsRNA protein kinase PKR: virus and cell control | Q28298945 | ||
| Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. | Q28609759 | ||
| Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures | Q29615028 | ||
| Coping with stress: eIF2 kinases and translational control | Q29619787 | ||
| Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase | Q29620280 | ||
| Proteasome inhibitors: valuable new tools for cell biologists | Q29620573 | ||
| Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction | Q31016943 | ||
| Interferon and its inducers--a never-ending story: "old" and "new" data in a new perspective | Q31055717 | ||
| TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. | Q33198557 | ||
| Cytosolic 5'-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response | Q33278262 | ||
| A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. | Q33316823 | ||
| Different effect of proteasome inhibition on vesicular stomatitis virus and poliovirus replication | Q33326624 | ||
| Protein synthesis shut-off induced by influenza virus infection is independent of PKR activity | Q33874625 | ||
| Hemorrhagic fever viruses as biological weapons: medical and public health management | Q34126496 | ||
| Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis | Q34625091 | ||
| Loss of PKR activity in chronic lymphocytic leukemia. | Q47207082 | ||
| Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study | Q57205447 | ||
| Pharmacogenomics of responsiveness to interferon IFN-beta treatment in multiple sclerosis: a genetic screen of 100 type I interferon-inducible genes | Q81596234 | ||
| Interferon, Mx, and viral countermeasures | Q34660504 | ||
| Activation of PKR by Bunyamwera virus is independent of the viral interferon antagonist NSs. | Q34975543 | ||
| NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. | Q35024013 | ||
| Rift Valley fever: an uninvited zoonosis in the Arabian peninsula | Q35077306 | ||
| Inverse interference: how viruses fight the interferon system | Q36020589 | ||
| Highly sensitive and broadly reactive quantitative reverse transcription-PCR assay for high-throughput detection of Rift Valley fever virus | Q36314304 | ||
| Inhibition of PKR by RNA and DNA viruses | Q36480640 | ||
| Viral modulators of cullin RING ubiquitin ligases: culling the host defense | Q36480678 | ||
| Viral hijacking of cellular ubiquitination pathways as an anti-innate immunity strategy | Q36598889 | ||
| Viral suppression of the interferon system | Q36750723 | ||
| The cellular 68,000-Mr protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: implications for translational regulation. | Q36827533 | ||
| Characterization of La Crosse virus small-genome transcripts | Q36912756 | ||
| Innate recognition of viruses | Q36950601 | ||
| PKR in innate immunity, cancer, and viral oncolysis | Q37064408 | ||
| An epizootic of Rift Valley fever in Egypt in 1977 | Q39240182 | ||
| The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice | Q39588385 | ||
| Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs | Q39601913 | ||
| T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus | Q39946457 | ||
| NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription | Q39960501 | ||
| 5'-triphosphate-dependent activation of PKR by RNAs with short stem-loops | Q40042442 | ||
| Germiston virus transcriptase requires active 40S ribosomal subunits and utilizes capped cellular RNAs | Q40063847 | ||
| Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter | Q40092449 | ||
| A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis | Q40167332 | ||
| Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene | Q40311587 | ||
| Cell-specific inhibition of paramyxovirus maturation by proteasome inhibitors | Q40371352 | ||
| Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease. | Q40453546 | ||
| Inhibition of host and viral translation during vesicular stomatitis virus infection. eIF2 is responsible for the inhibition of viral but not host translation. | Q40459832 | ||
| Inhibition of RNA polymerase II phosphorylation by a viral interferon antagonist | Q40554311 | ||
| Interferon-induced rat Mx proteins confer resistance to Rift Valley fever virus and other arthropod-borne viruses. | Q40595885 | ||
| Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study | Q40620063 | ||
| Rift Valley fever in rural northern Senegal: human risk factors and potential vectors. | Q40700580 | ||
| Pathogenesis of Rift Valley fever in rhesus monkeys: role of interferon response | Q40768376 | ||
| Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha. | Q40775763 | ||
| Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator | Q40806370 | ||
| Prophylactic and therapeutic efficacy of poly(I,C)-LC against Rift Valley fever virus infection in mice | Q40815181 | ||
| Protein synthesis in Rift Valley fever virus-infected cells | Q40827849 | ||
| Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection | Q40863327 | ||
| Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses | Q42425012 | ||
| Defective translational control facilitates vesicular stomatitis virus oncolysis | Q42831942 | ||
| The double-stranded RNA-activated protein kinase mediates viral-induced encephalitis | Q42832794 | ||
| Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. | Q43046800 | ||
| Dominant negative function by an alternatively spliced form of the interferon-inducible protein kinase PKR. | Q43559384 | ||
| Pathogenesis of Dugbe virus infection in wild-type and interferon-deficient mice | Q45415852 | ||
| Rapid decrease in the levels of the double-stranded RNA-dependent protein kinase during virus infections | Q45847989 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Rift Valley fever | Q326638 |
| Rift Valley fever virus | Q14276794 | ||
| Rift Valley fever phlebovirus | Q24809101 | ||
| P304 | page(s) | 4365-4375 | |
| P577 | publication date | 2009-02-11 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase | |
| P478 | volume | 83 |
| Q40186455 | A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep. |
| Q38614847 | A novel system for identification of inhibitors of rift valley Fever virus replication. |
| Q35027744 | A single vaccination with an improved nonspreading Rift Valley fever virus vaccine provides sterile immunity in lambs. |
| Q59335452 | A single-cycle replicable Rift Valley fever phlebovirus vaccine carrying a mutated NSs confers full protection from lethal challenge in mice |
| Q35616459 | A ΩXaV motif in the Rift Valley fever virus NSs protein is essential for degrading p62, forming nuclear filaments and virulence |
| Q37401773 | ADARs: viruses and innate immunity |
| Q39580797 | Activation of protein kinase R is required for induction of stress granules by respiratory syncytial virus but dispensable for viral replication |
| Q37945175 | Activation of the Antiviral Kinase PKR and Viral Countermeasures |
| Q28302608 | Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral |
| Q35077969 | Advances in Rift Valley fever research: insights for disease prevention |
| Q33927167 | Alteration in superoxide dismutase 1 causes oxidative stress and p38 MAPK activation following RVFV infection |
| Q42778332 | Alterations in the host transcriptome in vitro following Rift Valley fever virus infection |
| Q92876661 | Amazonian Phlebovirus (Bunyaviridae) potentiates the infection of Leishmania (Leishmania) amazonensis: Role of the PKR/IFN1/IL-10 axis |
| Q33359465 | Andes virus nucleocapsid protein interrupts protein kinase R dimerization to counteract host interference in viral protein synthesis |
| Q34031858 | Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice |
| Q54217244 | Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates. |
| Q37509225 | Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR. |
| Q56537260 | Bunyavirus: Hemorrhagic Fevers |
| Q38613824 | Bunyaviruses and the type I interferon system |
| Q34340654 | CD14 is a coreceptor of Toll-like receptors 7 and 9. |
| Q59351865 | CD4 T cells, CD8 T cells, and monocytes coordinate to prevent Rift Valley fever virus encephalitis |
| Q39194807 | CHD6, a cellular repressor of influenza virus replication, is degraded in human alveolar epithelial cells and mice lungs during infection |
| Q28486276 | Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virus |
| Q41935865 | Characterization of a PKR inhibitor from the pathogenic ranavirus, Ambystoma tigrinum virus, using a heterologous vaccinia virus system |
| Q40199478 | Comparative efficacy of two next-generation Rift Valley fever vaccines |
| Q38259045 | Coronavirus-induced ER stress response and its involvement in regulation of coronavirus-host interactions |
| Q33705717 | Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSs |
| Q38748778 | Creation of a recombinant Rift Valley fever virus with a two-segmented genome |
| Q36286082 | Curcumin inhibits Rift Valley fever virus replication in human cells. |
| Q41929716 | Current Status of Rift Valley Fever Vaccine Development |
| Q40123495 | Development of a sheep challenge model for Rift Valley fever. |
| Q36559849 | Dicer-2- and Piwi-mediated RNA interference in Rift Valley fever virus-infected mosquito cells |
| Q33443358 | Differential Antagonism of Human Innate Immune Responses by Tick-Borne Phlebovirus Nonstructural Proteins |
| Q47551088 | Differential effects of SUMO1 and SUMO3 on PKR activation and stability. |
| Q34704620 | Efficient cellular release of Rift Valley fever virus requires genomic RNA. |
| Q92667969 | Elongin C Contributes to RNA Polymerase II Degradation by the Interferon Antagonist NSs of La Crosse Orthobunyavirus |
| Q64097373 | Enhanced Replication of Mouse Adenovirus Type 1 following Virus-Induced Degradation of Protein Kinase R (PKR) |
| Q36874347 | Epidemiology, molecular virology and diagnostics of Schmallenberg virus, an emerging orthobunyavirus in Europe |
| Q38698634 | Foot-and-mouth disease virus induces lysosomal degradation of host protein kinase PKR by 3C proteinase to facilitate virus replication |
| Q34429914 | Functional analysis of Rift Valley fever virus NSs encoding a partial truncation |
| Q33420335 | Generation of mutant Uukuniemi viruses lacking the nonstructural protein NSs by reverse genetics indicates that NSs is a weak interferon antagonist |
| Q39664092 | Genetic reassortment between high-virulent and low-virulent Dobrava-Belgrade virus strains |
| Q44170263 | Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cells |
| Q38234190 | HIV-1 translation and its regulation by cellular factors PKR and PACT. |
| Q37673144 | Hantavirus immunology of rodent reservoirs: current status and future directions |
| Q21144476 | High content image-based screening of a protease inhibitor library reveals compounds broadly active against Rift Valley fever virus and other highly pathogenic RNA viruses |
| Q35893112 | High-Throughput Screening Using a Whole-Cell Virus Replication Reporter Gene Assay to Identify Inhibitory Compounds against Rift Valley Fever Virus Infection |
| Q24324685 | Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of type I interferon responses |
| Q33564101 | Human Herpesvirus 6A Exhibits Restrictive Propagation with Limited Activation of the Protein Kinase R-eIF2α Stress Pathway |
| Q24305895 | IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA |
| Q37036679 | IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus |
| Q33915111 | Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling |
| Q35801885 | Induction of DNA damage signaling upon Rift Valley fever virus infection results in cell cycle arrest and increased viral replication |
| Q34260234 | Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infection |
| Q38714315 | Influenza A Virus Virulence Depends on Two Amino Acids in the N-Terminal Domain of Its NS1 Protein To Facilitate Inhibition of the RNA-Dependent Protein Kinase PKR. |
| Q35076729 | Innate immune evasion mediated by the Ambystoma tigrinum virus eukaryotic translation initiation factor 2alpha homologue |
| Q34251382 | Innate immune response to Rift Valley fever virus in goats |
| Q52563024 | Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20. |
| Q38376184 | Interplay between the Virus and Host in Rift Valley Fever Pathogenesis |
| Q45372924 | Interventions Against West Nile Virus, Rift Valley Fever Virus, and Crimean-Congo Hemorrhagic Fever Virus: Where Are We? |
| Q40277454 | Large-scale chromatin immunoprecipitation with promoter sequence microarray analysis of the interaction of the NSs protein of Rift Valley fever virus with regulatory DNA regions of the host genome |
| Q96304864 | Livestock Challenge Models of Rift Valley Fever for Agricultural Vaccine Testing |
| Q35792819 | MP-12 virus containing the clone 13 deletion in the NSs gene prevents lethal disease when administered after Rift Valley fever virus infection in hamsters |
| Q28554535 | Mechanistic Insight into the Host Transcription Inhibition Function of Rift Valley Fever Virus NSs and Its Importance in Virulence |
| Q37254398 | Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist |
| Q36650409 | Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses |
| Q36489477 | Modifying the NSs gene to improve live-attenuated vaccine for Rift Valley fever. |
| Q57017486 | Molecular Biology of Rift Valley Fever Virus~!2009-11-04~!2009-11-25~!2010-04-22~! |
| Q59351098 | Molecular aspects of Rift Valley fever virus and the emergence of reassortants |
| Q36652695 | Molecular biology and genetic diversity of Rift Valley fever virus |
| Q33886954 | Molecular biology of rift valley Fever virus |
| Q35751132 | Monitoring activation of the antiviral pattern recognition receptors RIG-I and PKR by limited protease digestion and native PAGE. |
| Q54257544 | Mutation of adjacent cysteine residues in the NSs protein of Rift Valley fever virus results in loss of virulence in mice. |
| Q37049951 | Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression. |
| Q59352330 | NSs Protein of Sandfly Fever Sicilian Phlebovirus Counteracts Interferon (IFN) Induction by Masking the DNA-Binding Domain of IFN Regulatory Factor 3 |
| Q38774860 | NSs Virulence Factor of Rift Valley Fever Virus Engages the F-Box Proteins FBXW11 and β-TRCP1 To Degrade the Antiviral Protein Kinase PKR |
| Q96952294 | NSs amyloid formation is associated with the virulence of Rift Valley fever virus in mice |
| Q42218809 | NSs protein of Schmallenberg virus counteracts the antiviral response of the cell by inhibiting its transcriptional machinery |
| Q39547955 | NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62. |
| Q34220715 | Negative-strand RNA viruses: the plant-infecting counterparts |
| Q38150190 | Non-structural proteins of arthropod-borne bunyaviruses: roles and functions |
| Q40130716 | Nonspreading Rift Valley Fever Virus Infection of Human Dendritic Cells Results in Downregulation of CD83 and Full Maturation of Bystander Cells. |
| Q39778891 | Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects. |
| Q28354039 | Nonstructural Protein NSs of Schmallenberg Virus Is Targeted to the Nucleolus and Induces Nucleolar Disorganization |
| Q37252699 | Nuclear relocalization of polyadenylate binding protein during rift valley fever virus infection involves expression of the NSs gene |
| Q26747457 | Phleboviruses and the Type I Interferon Response |
| Q48097495 | Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection |
| Q36568775 | Presence of Viral RNA and Proteins in Exosomes from Cellular Clones Resistant to Rift Valley Fever Virus Infection |
| Q35912398 | Protein Kinase R Degradation Is Essential for Rift Valley Fever Virus Infection and Is Regulated by SKP1-CUL1-F-box (SCF)FBXW11-NSs E3 Ligase |
| Q52593226 | RLRs and TLRs Signaling Pathways Cause Aberrant Production of Inflammatory Cytokines/Chemokines in an SFTSV Infection Mouse Model. |
| Q36759999 | RNA helicase signaling is critical for type i interferon production and protection against Rift Valley fever virus during mucosal challenge |
| Q27491320 | Rapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNA |
| Q40221530 | Reactive oxygen species activate NFκB (p65) and p53 and induce apoptosis in RVFV infected liver cells |
| Q38614407 | Restriction of rift valley Fever virus virulence in mosquito cells |
| Q33419562 | Reverse genetics system for severe fever with thrombocytopenia syndrome virus |
| Q33570326 | Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines |
| Q35975309 | Rift Valley Fever Vaccine Virus Clone 13 Is Able to Cross the Ovine Placental Barrier Associated with Foetal Infections, Malformations, and Stillbirths |
| Q34475358 | Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments. |
| Q37006803 | Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice |
| Q36501737 | Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR. |
| Q26745530 | Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins |
| Q36827204 | Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses |
| Q40308414 | Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection. |
| Q92802082 | Rift Valley fever virus targets the maternal-foetal interface in ovine and human placentas |
| Q34221766 | Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep |
| Q33960690 | Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention |
| Q28539632 | Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model |
| Q34174444 | Rift valley fever: recent insights into pathogenesis and prevention |
| Q36501630 | Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep. |
| Q34233569 | Searching for cellular partners of hantaviral nonstructural protein NSs: Y2H screening of mouse cDNA library and analysis of cellular interactome |
| Q36127490 | Serum levels of inflammatory cytokines in Rift Valley fever patients are indicative of severe disease |
| Q37433779 | Short Interfering RNA Inhibits Rift Valley Fever Virus Replication and Degradation of Protein Kinase R in Human Cells |
| Q36326847 | Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates |
| Q35868079 | Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge |
| Q39734555 | Species-independent bioassay for sensitive quantification of antiviral type I interferons |
| Q33401401 | Suppression of the interferon and NF-κB responses by severe fever with thrombocytopenia syndrome virus |
| Q34734608 | Systems to establish bunyavirus genome replication in the absence of transcription |
| Q26796199 | Temperature-sensitive mutations for live-attenuated Rift Valley fever vaccines: implications from other RNA viruses |
| Q39709693 | The N-terminus of Bunyamwera orthobunyavirus NSs protein is essential for interferon antagonism |
| Q36442330 | The Non-structural Protein of Crimean-Congo Hemorrhagic Fever Virus Disrupts the Mitochondrial Membrane Potential and Induces Apoptosis |
| Q35097103 | The consequences of reconfiguring the ambisense S genome segment of Rift Valley fever virus on viral replication in mammalian and mosquito cells and for genome packaging |
| Q36155392 | The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine |
| Q40174551 | The genetic basis for susceptibility to Rift Valley fever disease in MBT/Pas mice |
| Q40306367 | The nonstructural protein NSs induces a variable antibody response in domestic ruminants naturally infected with Rift Valley fever virus |
| Q34191969 | The pathogenesis of Rift Valley fever |
| Q31034150 | The role of interferon antagonist, non-structural proteins in the pathogenesis and emergence of arboviruses |
| Q39672712 | The role of signal transducer and activator of transcription 3 in Rift Valley fever virus infection |
| Q37509231 | The two faces of Rift Valley fever virus virulence factor NSs: The development of a vaccine and the elucidation of pathogenesis |
| Q34055431 | Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles |
| Q34208420 | Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products |
| Q24337813 | Toscana virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I |
| Q36759758 | Toscana virus NSs protein promotes degradation of double-stranded RNA-dependent protein kinase |
| Q64938159 | Transcriptome profiling in Rift Valley fever virus infected cells reveals modified transcriptional and alternative splicing programs. |
| Q47560206 | Transmission of Rift Valley fever virus from European-breed lambs to Culex pipiens mosquitoes. |
| Q40134923 | Truncation of the C-terminal region of Toscana Virus NSs protein is critical for interferon-β antagonism and protein stability |
| Q35841573 | Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy |
| Q39296817 | Viperin, MTAP44, and protein kinase R contribute to the interferon-induced inhibition of Bunyamwera Orthobunyavirus replication |
| Q26314413 | Viral RNA Silencing Suppression: The Enigma of Bunyavirus NSs Proteins |
| Q64247484 | Viral Regulation of RNA Granules in Infected Cells |
| Q54279031 | Viral security proteins: counteracting host defences |
| Q37726462 | Viral strategies to subvert the mammalian translation machinery |
| Q37764230 | Viral tricks to grid-lock the type I interferon system |
| Q38326807 | Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH |
| Q26700102 | Who Regulates Whom? An Overview of RNA Granules and Viral Infections |
| Q97519293 | eIF2B as a Target for Viral Evasion of PKR-Mediated Translation Inhibition |
| Q24319790 | p53 Activation following Rift Valley fever virus infection contributes to cell death and viral production |
Search more.